Kristina Byrd
Family · Booneville, KYNPI 1326498338
Payments from drug & device makers
Across 391 payments — averaging $12.68 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$1K
- AbbVie$1K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$756
- Amgen$269
- Biodelivery Sciences International, Inc.$220
- Indivior Inc.$215
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,91399%
- Education$471%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 131 | $1,120 |
| AbbVie | 82 | $1,103 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 51 | $756 |
| Amgen | 14 | $269 |
| Biodelivery Sciences International, Inc. | 24 | $220 |
| Indivior Inc. | 10 | $215 |
| Alkermes, Inc. | 10 | $174 |
| Vanda Pharmaceuticals Inc. | 8 | $157 |
| Otsuka America Pharmaceutical, Inc. | 7 | $130 |
| Biohaven Pharmaceutical Holding Company Ltd. | 12 | $124 |
| Redhill Biopharma Inc. | 6 | $98 |
| Lilly USA, LLC | 6 | $85 |
| Axsome Therapeutics, Inc. | 2 | $60 |
| Novo Nordisk | 4 | $56 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $47 |
| AstraZeneca | 3 | $46 |
| Johnson & Johnson | 2 | $42 |
| Dexcom, Inc. | 2 | $35 |
| Gilead | 2 | $31 |
| Novartis | 2 | $29 |
| Verona Pharma, Inc. | 1 | $22 |
| Orexo US, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $17 |
| GSK | 1 | $17 |
| Amarin Pharma, Inc. | 1 | $16 |
| Nestle Healthcare Nutrition Inc. | 1 | $15 |
| Astellas Pharma US Inc | 1 | $14 |
| Braeburn Inc. | 1 | $14 |
| Almatica Pharma LLC | 1 | $14 |
| Teva Pharmaceuticals USA, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- CAPLYTA$125
How this compares
$4,960 in reported general payments places this provider in the 90th percentile of 4,374 family providers in Kentucky.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RelistorMethylnaltrexone Bromide | 27 | $62,885 |
| OzempicSemaglutide | 32 | $31,377 |
| MounjaroTirzepatide | 24 | $24,692 |
| LinzessLinaclotide | 38 | $23,863 |
| JardianceEmpagliflozin | 17 | $15,808 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 18 | $12,856 |
| Buprenorphine-NaloxoneBuprenorphine Hcl/Naloxone Hcl | 230 | $12,803 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 15 | $10,908 |
| BrilintaTicagrelor | 24 | $10,551 |
| FarxigaDapagliflozin Propanediol | 13 | $9,532 |
| Repatha SureclickEvolocumab | 16 | $8,831 |
| Ondansetron Hcl | 39 | $7,673 |
| VascepaIcosapent Ethyl | 14 | $6,260 |
| SymbicortBudesonide/Formoterol Fumarate | 11 | $4,500 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 243 | $4,272 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLCRelistor | $1,120 | $62,88527 claims |
| Novo NordiskOzempic | $56 | $31,37732 claims |
| Lilly USA, LLCMounjaro | $85 | $24,69224 claims |
| AstraZenecaBrilinta, Farxiga, Symbicort | $46 | $24,58348 claims |
| AbbVieLinzess | $1,103 | $23,86338 claims |
| GSKAnoro Ellipta | $17 | $12,85618 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 4,374 family providers in Kentucky.
Other family in Booneville
- Bonnie HillLouisa$372K
- Ashley SnellenElizabethtown$190K
- Smita RanjanLouisville$92K
- Elizabeth SaltLexington$89K
- Tracey GaslinLouisville$79K
- Kassandra GreenLouisville$69K
- Danielle RevertLouisville$65K
- Lora BrownMonticellow$61K
- Shelley WaldmanLouisville$59K
- Vicki ChapmanMount Vernon$57K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.